{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:55:57Z","timestamp":1790754957354,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.bbrc.2012.10.055","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T09:31:19Z","timestamp":1350898279000},"page":"315-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A mice"],"prefix":"10.1016","volume":"428","author":[{"given":"Mayumi","family":"Takada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsugu","family":"Akagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2012.10.055_b0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1463-1326.2011.01536.x","article-title":"Obesity and type 2 diabetes: which patients are at risk?","volume":"14","author":"Garber","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbrc.2012.10.055_b0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0092-8674(01)00239-2","article-title":"New perspectives into the molecular pathogenesis and treatment of type 2 diabetes","volume":"104","author":"Saltiel","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2012.10.055_b0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1185\/030079903125002351","article-title":"Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus","volume":"19","author":"Fonseca","year":"2003","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bbrc.2012.10.055_b0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2012.10.055_b0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2012.10.055_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1006868409841","article-title":"Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction","volume":"182","author":"Byon","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2012.10.055_b0035","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1074\/jbc.271.33.19810","article-title":"Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling","volume":"271","author":"Kenner","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.10.055_b0040","doi-asserted-by":"crossref","first-page":"24844","DOI":"10.1074\/jbc.M310688200","article-title":"Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action","volume":"279","author":"Zabolotny","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.10.055_b0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI119552","article-title":"Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes","volume":"100","author":"Ahmad","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2012.10.055_b0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-2143(99)90115-4","article-title":"Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus","volume":"134","author":"Cheung","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bbrc.2012.10.055_b0055","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/db11-0744","article-title":"Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans","volume":"61","author":"Stull","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2012.10.055_b0060","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2012.10.055_b0065","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1128\/MCB.20.15.5479-5489.2000","article-title":"Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice","volume":"20","author":"Klaman","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2012.10.055_b0070","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1073\/pnas.142298199","article-title":"PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice","volume":"99","author":"Zinker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2012.10.055_b0075","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bbrc.2004.08.138","article-title":"Reduction of PTP1B induces differential expression of PI3-kinase (p85alpha) isoforms","volume":"323","author":"Rondinone","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2012.10.055_b0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2011.06.009","article-title":"Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control","volume":"410","author":"Popov","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2012.10.055_b0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jn\/130.4.719","article-title":"Physiological importance of quinoenzymes and the o-quinone family of cofactors","volume":"130","author":"Stites","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbrc.2012.10.055_b0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0304-4165(92)90096-D","article-title":"Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography\/mass spectrometry","volume":"1156","author":"Kumazawa","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2012.10.055_b0095","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/bj3070331","article-title":"Levels of pyrroloquinoline quinone in various foods","volume":"307","author":"Kumazawa","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2012.10.055_b0100","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.freeradbiomed.2012.07.015","article-title":"Pyrroloquinoline quinone stimulates epithelial cell proliferation by activating epidermal growth factor receptor through redox cycling","volume":"53","author":"Kimura","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2012.10.055_b0105","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1271\/bbb.70342","article-title":"Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane","volume":"71","author":"Nishiumi","year":"2007","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bbrc.2012.10.055_b0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1039\/C0MB00089B","article-title":"Novel use of fluorescent glucose analogues to identify a new class of triazine-based insulin mimetics possessing useful secondary effects","volume":"7","author":"Jung","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.bbrc.2012.10.055_b0115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.21643","article-title":"Redox-dependent and ligand-independent trans-activation of insulin receptor by globular adiponectin","volume":"46","author":"Fiaschi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2012.10.055_b0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.embor.embor767","article-title":"Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells","volume":"4","author":"Boute","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbrc.2012.10.055_b0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12038-012-9195-5","article-title":"Pyrroloquinoline-quinone and its versatile roles in biological processes","volume":"37","author":"Misra","year":"2012","journal-title":"J. Biosci."},{"key":"10.1016\/j.bbrc.2012.10.055_b0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0968-0004(03)00174-9","article-title":"Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction","volume":"28","author":"Chiarugi","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2012.10.055_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/aps.2012.90","article-title":"Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades","author":"Jiang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2012.10.055_b0140","first-page":"268","article-title":"Potential physiological importance of pyrroloquinoline quinone","volume":"14","author":"Rucker","year":"2009","journal-title":"Altern. Med. Rev."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12020098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12020098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:26:57Z","timestamp":1762093617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X12020098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0006291X12020098"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.10.055","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-Ay mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.10.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}